ARTICLE | Company News
Alliance submits Imavist response to FDA
August 20, 2001 7:00 AM UTC
ALLP said it submitted its response to the FDA's issues in the agency's August 2000 approvable letter for ALLP's Imavist (AF0150) ultrasound contrast agent. ALLP and partner Schering (SHR) received an...